Giacomo Basadonna to Antibodies, Monoclonal
This is a "connection" page, showing publications Giacomo Basadonna has written about Antibodies, Monoclonal.
Connection Strength
0.401
-
Rothstein DM, Livak MF, Kishimoto K, Ariyan C, Qian HY, Fecteau S, Sho M, Deng S, Zheng XX, Sayegh MH, Basadonna GP. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol. 2001 Jan 01; 166(1):322-9.
Score: 0.132
-
Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Onodera H, Lazarovits AI, Basadonna GP. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation. 1997 May 15; 63(9):1355-8.
Score: 0.103
-
Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Basadonna GP. Anti-CD45RB treatment prolongs islet allograft survival in mice. Transplant Proc. 1997 Feb-Mar; 29(1-2):771.
Score: 0.101
-
Molano RD, Berney T, Pileggi A, Ricordi C, Burkly L, Rothstein D, Basadonna G, Inverardi L. Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies. Transplant Proc. 2001 Feb-Mar; 33(1-2):248-9.
Score: 0.033
-
Salvalaggio PR, Camirand G, Ariyan CE, Deng S, Rogozinski L, Basadonna GP, Rothstein DM. Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo. J Immunol. 2006 Feb 15; 176(4):2292-8.
Score: 0.012
-
Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol. 2003 Dec 01; 171(11):5673-7.
Score: 0.010
-
Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Ricordi C, Rothstein DM, Basadonna GP, Inverardi L. Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes. 2003 Apr; 52(4):957-64.
Score: 0.010